Page last updated: 2024-10-27

gentamicin and Hemophilia B

gentamicin has been researched along with Hemophilia B in 1 studies

Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Hemophilia B: A deficiency of blood coagulation factor IX inherited as an X-linked disorder. (Also known as Christmas Disease, after the first patient studied in detail, not the holy day.) Historical and clinical features resemble those in classic hemophilia (HEMOPHILIA A), but patients present with fewer symptoms. Severity of bleeding is usually similar in members of a single family. Many patients are asymptomatic until the hemostatic system is stressed by surgery or trauma. Treatment is similar to that for hemophilia A. (From Cecil Textbook of Medicine, 19th ed, p1008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Branchini, A1
Ferrarese, M1
Campioni, M1
Castaman, G1
Mari, R1
Bernardi, F1
Pinotti, M1

Other Studies

1 other study available for gentamicin and Hemophilia B

ArticleYear
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations.
    Blood, 2017, 04-20, Volume: 129, Issue:16

    Topics: Amino Acid Substitution; Arginine; Codon, Nonsense; Factor IX; Gene Expression Regulation; Gentamici

2017